Antidepressants, β-Arrestins and GRKs: From Regulation of Signal Desensitization to Intracellular Multifunctional Adaptor Functions
Abstract
G protein-coupled receptors (GPCR) have generated considerable interest in the pharmaceutical industry as drug targets. Theories concerning antidepressant targets of action suggested pre-synaptic monoamine reuptake mechanisms regulating GPCR activities including delayed receptor desensitization and down-regulation. GRKs and beta-arrestins translocate to the cell membrane and bind to agonist-occupied receptors. This uncouples these receptors from G proteins and promotes their internalization, leading to desensitization and down-regulation. Thus, GRKs and beta-arrestins serve as negative regulators of GPCR signaling. Recently, GPCR have been demonstrated to elicit signals through interaction with beta-arrestin as scaffolding proteins, independent of heterotrimeric G-protein coupling. beta-arrestins function as scaffold proteins that interact with several cytoplasmic proteins and link GPCR to intracellular signaling pathways such as MAPK cascades. Recent work has also revealed that beta-arrestins translocate from the cytoplasm to the nucleus and associate with transcription cofactors such as p300 and CREB. They also interact with regulators of transcription factors. We review findings concerning effects of antidepressants on GRKs and beta-arrestins and the plethora of antidepressants effects on signal transduction elements in which GRKs and beta-arrestins serve as signaling scaffold proteins, and on transcription factors and cofactors in which beta-arrestins mediate regulation of transcription. The emergence of G-protein-independent signaling pathways, through beta-arrestins, changes the way in which GPCR signaling is evaluated, from a cell biological to a pharmaceutical perspective and raises the possibility for the development of pathway specific therapeutics e.g., antidepressant medications targeting GRKs and beta-arrestin regulatory and signaling proteins.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The genes chosen for expression analysis have all recently been implicated in antidepressant drug action and neurogenesis.
“These genes were chosen because they have all recently been implicated in antidepressant drug action and neurogenesis.35, 36, 37, 38, 39, 12, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49”
From Antidepressants increase human hippocampal neurogenesis by activating the glucocorticoid receptor (2011) · cites this paper as [41]
Cites
Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)
Hu, R. J. (2003) · Elsevier eBooks · doi:10.1016/b0-12-226870-9/01070-4 · Cited by 9,167 · see citing works
(1996) · Cited by 6,884 · see citing works
THE CATECHOLAMINE HYPOTHESIS OF AFFECTIVE DISORDERS: A REVIEW OF SUPPORTING EVIDENCE
Schildkraut, J. J. (1965) · American Journal of Psychiatry · doi:10.1176/ajp.122.5.509 · Cited by 3,499 · see citing works
Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs
Creese, I., Burt, D. R., & Snyder, S. H. (1976) · Science · doi:10.1126/science.3854 · Cited by 2,220 · see citing works
A molecular and cellular theory of depression
Duman, R. S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830190015002 · Cited by 2,129 · see citing works
Ferguson, S. S. G. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01478-9 · Cited by 1,827 · see citing works
Antipsychotic drug doses and neuroleptic/dopamine receptors
SEEMAN, P., LEE, T., CHAU-WONG, M., & WONG, K. (1976) · Nature · doi:10.1038/261717a0 · Cited by 1,622 · see citing works
β-Arrestin-Dependent Formation of β 2 Adrenergic Receptor-Src Protein Kinase Complexes
Luttrell, L. M., Ferguson, S. S. G., Daaka, Y., Miller, W. E., Maudsley, S. R., Rocca, G. J. D., Lin, F., Kawakatsu, H., Owada, K. M., Luttrell, D. K., et al. (1999) · Science · doi:10.1126/science.283.5402.655 · Cited by 1,473 · see citing works
β-Arrestin acts as a clathrin adaptor in endocytosis of the β2-adrenergic receptor
Goodman, O. B., Krupnick, J. G., Santini, F., Gurevich, V. V., Penn, R. B., Gagnon, A. W., Keen, J. H., & Benovic, J. (1996) · Nature · doi:10.1038/383447a0 · Cited by 1,383 · see citing works
G PROTEIN–COUPLED RECEPTOR KINASES
Pitcher, J. A., Freedman, N. J., & Lefkowitz, R. J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.653 · Cited by 1,379 · see citing works
β-Arrestin: a Protein that Regulates β-adrenergic Receptor Function
Lohse, M. J., Benovic, J., Codina, J., Caron, M. G., & Lefkowitz, R. J. (1990) · Science · doi:10.1126/science.2163110 · Cited by 1,222 · see citing works
Lithium salts in the treatment of psychotic excitement
Cade, J. F. (1999) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/j.1440-1614.1999.06241.x · Cited by 1,146 · see citing works
A cholinergic-adrenergic hypothesis of mania and depression
Janowsky, D., Davis, J., El-Yousef, M. K., & Sekerke, H. J. (1972) · The Lancet · doi:10.1016/s0140-6736(72)93021-8 · Cited by 1,134 · see citing works
The role of β-arrestins in the termination and transduction of G-protein-coupled receptor signals
Luttrell, L. M., & Lefkowitz, R. J. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.3.455 · Cited by 1,123 · see citing works
An Akt/β-Arrestin 2/PP2A Signaling Complex Mediates Dopaminergic Neurotransmission and Behavior
Beaulieu, J., Sotnikova, T. D., Marion, S., Lefkowitz, R. J., Gainetdinov, R. R., & Caron, M. G. (2005) · Cell · doi:10.1016/j.cell.2005.05.012 · Cited by 980 · see citing works
DESENSITIZATION OF G PROTEIN–COUPLED RECEPTORS AND NEURONAL FUNCTIONS
Gainetdinov, R. R., Premont, R. T., Bohn, L., Lefkowitz, R. J., & Caron, M. G. (2004) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.27.070203.144206 · Cited by 864 · see citing works
Long-Term Antidepressant Treatment Decreases Spiroperidol-Labeled Serotonin Receptor Binding
Peroutka, S. J., & Snyder, S. H. (1980) · Science · doi:10.1126/science.6251550 · Cited by 837 · see citing works
Activation and targeting of extracellular signal-regulated kinases by β-arrestin scaffolds
Luttrell, L. M., Roudabush, F. L., Choy, E. W., Miller, W. E., Field, M. E., Pierce, K. L., & Lefkowitz, R. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041604898 · Cited by 832 · see citing works
DeFea, K., Zalevsky, J., Thoma, M. S., Déry, O., Mullins, R. D., & Bunnett, N. W. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.148.6.1267 · Cited by 820 · see citing works
β-Arrestin 2: A Receptor-Regulated MAPK Scaffold for the Activation of JNK3
McDonald, P. H., Chow, C.-W., Miller, W. E., Laporte, S. A., Field, M. E., Lin, F., Davis, R. J., & Lefkowitz, R. J. (2000) · Science · doi:10.1126/science.290.5496.1574 · Cited by 818 · see citing works
Development of β-adrenergic receptor subsensitivity by antidepressants
Banerjee, S. P., Kung, L. S., Riggi, S. J., & Chanda, S. K. (1977) · Nature · doi:10.1038/268455a0 · Cited by 722 · see citing works
Lapin, I. P., & Oxenkrug, G. F. (1969) · The Lancet · doi:10.1016/s0140-6736(69)91140-4 · Cited by 710 · see citing works
GRKs and β-arrestins: roles in receptor silencing, trafficking and signaling
Reiter, É., & Lefkowitz, R. J. (2006) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2006.03.008 · Cited by 680 · see citing works
The β 2 -adrenergic receptor/βarrestin complex recruits the clathrin adaptor AP-2 during endocytosis
Laporte, S. A., Oakley, R. H., Zhang, J., Holt, J. A., Ferguson, S. S. G., Caron, M. G., & Barak, L. S. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3712 · Cited by 634 · see citing works
Vetulani, J., & Sulser, F. (1975) · Nature · doi:10.1038/257495a0 · Cited by 596 · see citing works
Oakley, R. H., Laporte, S. A., Holt, J. A., Barak, L. S., & Caron, M. G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.32248 · Cited by 567 · see citing works
Desensitization of G-protein-coupled Receptors
Xiao, Z., Yao, Y., Yu, L., & Devreotes, P. N. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.3.1440 · Cited by 521 · see citing works
Overview: toward a dysregulation hypothesis of depression
Siever, L. J., & Davis, K. L. (1985) · American Journal of Psychiatry · doi:10.1176/ajp.142.9.1017 · Cited by 518 · see citing works
GTP-dependent segregation of H-ras from lipid rafts is required for biological activity
Prior, I. A., Harding, A. S., Yan, J., Sluimer, J. C., Parton, R. G., & Hancock, J. F. (2001) · Nature Cell Biology · doi:10.1038/35070050 · Cited by 513 · see citing works
Ahn, S., Shenoy, S. K., Wei, H., & Lefkowitz, R. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405878200 · Cited by 508 · see citing works
cAMP Response Element-Mediated Gene Transcription Is Upregulated by Chronic Antidepressant Treatment
Thome, J., Sakai, N., Shin, K.-H., Steffen, C., Zhang, Y.-J., Impey, S., Storm, D. R., & Duman, R. S. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04030.2000 · Cited by 507 · see citing works
Koch, W. J., Inglese, J., Stone, W. C., & Lefkowitz, R. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53090-8 · Cited by 475 · see citing works
The Role of the Extracellular Signal-Regulated Kinase Signaling Pathway in Mood Modulation
Einat, H., Yuan, P., Gould, T. D., Li, J., Du, J., Zhang, L., Manji, H. K., & Chen, G. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-19-07311.2003 · Cited by 475 · see citing works
Wolfe, B. B., Harden, T. K., Sporn, J. R., et al. (1978) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)31441-2 · Cited by 452 · see citing works
Bouvier, M., Hausdorff, W. P., Blasi, A. D., O’Dowd, B. F., Kobilka, B. K., Caron, M. G., & Lefkowitz, R. J. (1988) · Nature · doi:10.1038/333370a0 · Cited by 437 · see citing works
Historical review: A brief history and personal retrospective of seven-transmembrane receptors
Lefkowitz, R. J. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.06.006 · Cited by 415 · see citing works
DeFea, K., Vaughn, Z. D., O’Bryan, E., Nishijima, D., Déry, O., & Bunnett, N. W. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.190276697 · Cited by 405 · see citing works
Shenoy, S. K., & Lefkowitz, R. J. (2003) · Biochemical Journal · doi:10.1042/bj20031076 · Cited by 402 · see citing works
Tohgo, A., Pierce, K. L., Choy, E. W., Lefkowitz, R. J., & Luttrell, L. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106457200 · Cited by 396 · see citing works
The Role of CREB in Depression and Antidepressant Treatment
Blendy, J. A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.11.003 · Cited by 365 · see citing works
A β-arrestin 2 Signaling Complex Mediates Lithium Action on Behavior
Beaulieu, J., Marion, S., Rodriguiz, R. M., Medvedev, I. O., Sotnikova, T. D., Ghisi, V., Wetsel, W. C., Lefkowitz, R. J., Gainetdinov, R. R., & Caron, M. G. (2008) · Cell · doi:10.1016/j.cell.2007.11.041 · Cited by 362 · see citing works
Tohgo, A., Choy, E. W., Gesty‐Palmer, D., Pierce, K. L., Laporte, S. A., Oakley, R. H., Caron, M. G., Lefkowitz, R. J., & Luttrell, L. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212231200 · Cited by 360 · see citing works
Dwivedi, Y., Rizavi, H. S., Roberts, R. C., Conley, R. C., Tamminga, C. A., & Pandey, G. N. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00300.x · Cited by 333 · see citing works
Kang, J., Shi, Y., Xiang, B., Qu, B., Su, W., Zhu, M., Zhang, M., Bao, G., Wang, F., Zhang, X., et al. (2005) · Cell · doi:10.1016/j.cell.2005.09.011 · Cited by 317 · see citing works
Chen, A. C. H., Shirayama, Y., Shin, K.-H., Neve, R. L., & Duman, R. S. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01114-8 · Cited by 314 · see citing works
Identification of β-Arrestin2 as a G Protein-Coupled Receptor-Stimulated Regulator of NF-κB Pathways
Gao, H., Sun, Y., Wu, Y., Luan, B., Wang, Y., Qu, B., & Pei, G. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00216-3 · Cited by 313 · see citing works
Prange, A. J. (1974) · Archives of General Psychiatry · doi:10.1001/archpsyc.1974.01760070040006 · Cited by 275 · see citing works
β-arrestin signaling and regulation of transcription
Ma, L., & Pei, G. (2007) · Journal of Cell Science · doi:10.1242/jcs.03338 · Cited by 268 · see citing works
β-Arrestin inhibits NF-κB activity by means of its interaction with the NF-κB inhibitor IκBα
Witherow, D. S., Garrison, T. R., Miller, W. E., & Lefkowitz, R. J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402851101 · Cited by 254 · see citing works
Lin, F., Krueger, K. M., Kendall, H. E., Daaka, Y., Fredericks, Z. L., Pitcher, J. A., & Lefkowitz, R. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.49.31051 · Cited by 246 · see citing works
[Treatment of depressive states with an iminodibenzyl derivative (G 22355)].
KUHN, R. (1957) · PubMed · Cited by 245 · see citing works
Zhang, J., Barak, L. S., Winkler, K. E., Caron, M. G., & Ferguson, S. S. G. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.43.27005 · Cited by 238 · see citing works
Mitogen-Activated Protein Kinase Signaling
Kyosseva, S. V. (2004) · International review of neurobiology · doi:10.1016/s0074-7742(04)59008-6 · Cited by 234 · see citing works
Arresting developments in heptahelical receptor signaling and regulation
Perry, S. J., & Lefkowitz, R. J. (2002) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)02239-5 · Cited by 217 · see citing works
Gagnon, A. W., Kallal, L. A., & Benovic, J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.12.6976 · Cited by 216 · see citing works
Differential Nucleocytoplasmic Shuttling of β-Arrestins
Scott, M. G. H., Rouzic, E. L., Périanin, A., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207552200 · Cited by 216 · see citing works
Light-dependent phosphorylation of rhodopsin by β-adrenergic receptor kinase
Benovic, J., Mayor, F., Somers, R. L., et al. (1986) · Nature · doi:10.1038/321869a0 · Cited by 211 · see citing works
Niculescu, A. B., Segal, D. S., Kuczenski, R. T., Barrett, T. B., Hauger, R. L., & Kelsoe, J. R. (2000) · Physiological Genomics · doi:10.1152/physiolgenomics.2000.4.1.83 · Cited by 206 · see citing works
A clinical and pharmacodynamic evaluation of iproniazid as a psychic energizer.
Loomer, H. P., SAUNDERS, J. C., & Kline, N. S. (1957) · PubMed · Cited by 205 · see citing works
The Identification of Ligands at Orphan G-Protein Coupled Receptors
Wise, A., Jupe, S., & Rees, S. (2004) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121419 · Cited by 201 · see citing works
Pitcher, J. A., Tesmer, J. J. G., Freeman, J. L. R., Capel, W. D., Stone, W. C., & Lefkowitz, R. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.49.34531 · Cited by 187 · see citing works
Inhibition of glial inflammatory activation and neurotoxicity by tricyclic antidepressants
Hwang, J., Zheng, L. T., Ock, J., Lee, M. G., Kim, S.-H., Lee, H.-W., Lee, W.-H., Park, H.-C., & Suk, K. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.06.045 · Cited by 181 · see citing works
MAP Kinase Activation by Fluoxetine and Its Relation to Gene Expression in Cultured Rat Astrocytes
Mercier, G., Lennon, A. M., Renouf, B., Dessouroux, A., Ramaugé, M., Courtin, F., & Pierre, M. (2004) · Journal of Molecular Neuroscience · doi:10.1385/jmn:24:2:207 · Cited by 176 · see citing works
Winstel, R., Freund, S. M. V., Krasel, C., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.5.2105 · Cited by 171 · see citing works
Phosphorylation and Activation of β-Adrenergic Receptor Kinase by Protein Kinase C
Chuang, T. T., LeVine, H., & Blasi, A. D. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.31.18660 · Cited by 163 · see citing works
Wang, P., Wu, Y., Ge, X., Ma, L., & Pei, G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208109200 · Cited by 161 · see citing works
β‐arrestins and heterotrimeric G‐proteins: collaborators and competitors in signal transduction
DeFea, K. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707508 · Cited by 159 · see citing works
Garcı́a-Sevilla, J. A., Escribá, P. V., Ozaita, A., Harpe, R. L., Walzer, C., Eytan, A., & Guimón, J. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0720282.x · Cited by 154 · see citing works
Marzo, V. D., Starowicz, K., & Cristino, L. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208783330790 · Cited by 153 · see citing works
Current status of antidepressants: clinical pharmacology and therapy.
Baldessarini, R. J. (1989) · PubMed · Cited by 153 · see citing works
CREB, neurogenesis and depression
Gass, P., & Riva, M. A. (2007) · BioEssays · doi:10.1002/bies.20658 · Cited by 150 · see citing works
Pathophysiological roles of G-protein-coupled receptor kinases
Métayé, T., Gibelin, H., Perdrisot, R., & Kraimps, J. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.01.002 · Cited by 145 · see citing works
Feedback Regulation of β-Arrestin1 Function by Extracellular Signal-regulated Kinases
Lin, F., Miller, W. E., Luttrell, L. M., & Lefkowitz, R. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.23.15971 · Cited by 144 · see citing works
Menkes, D. B., Rasenick, M. M., Wheeler, M. A., & Bitensky, M. W. (1983) · Science · doi:10.1126/science.6849117 · Cited by 144 · see citing works
Critical regulation of CD4+ T cell survival and autoimmunity by β-arrestin 1
Shi, Y., Feng, Y., Kang, J., Liu, C., Li, Z., Li, D., Cao, W., Qiu, J., Guo, Z., Bi, E., et al. (2007) · Nature Immunology · doi:10.1038/ni1489 · Cited by 141 · see citing works
X‐Arrestin: a new retinal arrestin mapping to the X chromosome
Murakami, A., Yajima, T., Sakuma, H., McLaren, M. J., & Inana, G. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)81712-9 · Cited by 127 · see citing works
Dwivedi, Y., Rizavi, H. S., Conley, R. R., & Pandey, G. N. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001744 · Cited by 123 · see citing works
Parruti, G., Peracchia, F., Sallese, M., Ambrosini, G., Masini, M., Rotilio, D., & Blasi, A. D. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98412-7 · Cited by 116 · see citing works
GTP‐Binding–Protein‐Coupled Receptor Kinases Two Mechanistic Models
Palczewski, K. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00261.x · Cited by 116 · see citing works
Barrett, T. B., Hauger, R. L., Kennedy, J. L., Sadovnick, A. D., Remick, R. A., Keck, P. E., McElroy, S. L., Alexander, M., Shaw, S. H., & Kelsoe, J. R. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001268 · Cited by 116 · see citing works
Allen, J., Yu, J. Z., Donati, R. J., & Rasenick, M. M. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.008342 · Cited by 110 · see citing works
Sarnago, S., Elorza, A., & Mayor, F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.48.34411 · Cited by 109 · see citing works
Avissar, S., & Schreiber, G. (1992) · Biological Psychiatry · doi:10.1016/0006-3223(92)90257-z · Cited by 106 · see citing works
Self-citationGinovart, N., Farde, L., Halldin, C., & Swahn, C. (1997) · Synapse · doi:10.1002/(sici)1098-2396(199704)25:4 · Cited by 105 · see citing works
The New Face of Active Receptor Bound Arrestin Attracts New Partners
Gurevich, V. V., & Gurevich, E. V. (2003) · Structure · doi:10.1016/s0969-2126(03)00184-9 · Cited by 104 · see citing works
Laifenfeld, D., Karry, R., Grauer, E., Klein, E., & Ben-Shachar, D. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.03.023 · Cited by 103 · see citing works
Phosphorylation of β-Arrestin2 Regulates Its Function in Internalization of β2-Adrenergic Receptors
Lin, F., Chen, W. R., Shenoy, S. K., et al. (2002) · Biochemistry · doi:10.1021/bi025705n · Cited by 101 · see citing works
G protein signaling and the molecular basis of antidepressant action
Donati, R. J., & Rasenick, M. M. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00249-2 · Cited by 97 · see citing works
Mitogen-activated protein kinases in schizophrenia
Kyosseva, S. V., Elbein, A. D., Griffin, W. S. T., et al. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00104-3 · Cited by 89 · see citing works
Shen, C., Li, H., & Meller, E. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00064-3 · Cited by 80 · see citing works
Chiou, S., Ku, H., Tsai, T., Lin, H., Chen, L., Chien, C., Ho, L. L. ‐., Lee, C., & Chang, Y. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706766 · Cited by 73 · see citing works
Chen, T. C., Wadsten, P., Su, S., et al. (2002) · Cancer Biology & Therapy · doi:10.4161/cbt.80 · Cited by 72 · see citing works
CREB Binding and Activity in Brain: Regional Specificity and Induction by Electroconvulsive Seizure
Tanis, K. Q., Duman, R. S., & Newton, S. S. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.08.003 · Cited by 68 · see citing works
Huang, Y.-Y., Peng, C.-H., Yang, Y.-P., Wu, C.-C., Hsu, W., Wang, H.-J., Chan, K.-H., Chou, Y., Chen, S., & Chang, Y.-L. (2007) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fp0061255 · Cited by 65 · see citing works
Cell‐based assays in GPCR drug discovery
Siehler, S. (2008) · Biotechnology Journal · doi:10.1002/biot.200800001 · Cited by 64 · see citing works
Intracellular signaling pathways pave roads to recovery for mood disorders
Tanis, K. Q., & Duman, R. S. (2007) · Annals of Medicine · doi:10.1080/07853890701483270 · Cited by 63 · see citing works
Avissar, S., Ruban, A., Tzukert, K., et al. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.11.2066 · Cited by 61 · see citing works
Self-citationHa, E., Jung, K. H., Choe, B., Bae, J., Shin, D.-H., Yim, S., & Baik, H. H. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2005.12.022 · Cited by 60 · see citing works
Slattery, D. A., Morrow, J. A., Hudson, A. L., Hill, D. R., Nutt, D., & Henry, B. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300717 · Cited by 60 · see citing works
Bartholomä, P., Erlandsson, N., Kaufmann, K., Rößler, O. G., Baumann, B., Wirth, T., Giehl, K. M., & Thiel, G. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)00882-1 · Cited by 56 · see citing works
Chen, S., Kao, C.-L., Chang, Y., Yen, C.-J., Shui, J.-W., Chien, C.-S., Chen, I.-L., Tsai, T., Ku, H., & Chiou, S. (2007) · Current Neurovascular Research · doi:10.2174/156720207779940707 · Cited by 56 · see citing works
Fishman, P. H., & Finberg, J. P. M. (1987) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1987.tb03427.x · Cited by 55 · see citing works
Kuipers, S. D., Trentani, A., Westenbroek, C., Bramham, C. R., Korf, J., Kema, I. P., Horst, G. J. T., & den Boer, J. A. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.10.006 · Cited by 54 · see citing works
Cristalli, G., Lambertucci, C., Marucci, G., et al. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208784480081 · Cited by 54 · see citing works
Mo, W., Zhang, L., Yang, G., Zhai, J., Hu, Z., Chen, Y., Chen, X., Hui, L., Huang, R., & Hu, G. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.06.017 · Cited by 51 · see citing works
Honegger, U. E., Disler, B., & WIESMANN, U. N. (1986) · Biochemical Pharmacology · doi:10.1016/0006-2952(86)90309-6 · Cited by 49 · see citing works
Menegazzi, M., Novelli, M., Beffy, P., D’Aleo, V., Tedeschi, E., Lupi, R., Zoratti, E., Marchetti, P., Suzuki, H., & Masiello, P. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.11.019 · Cited by 46 · see citing works
Grange-Midroit, M. (2003) · Molecular Brain Research · doi:10.1016/s0169-328x(02)00667-8 · Cited by 45 · see citing works
Beaulieu, J., & Caron, M. G. (2005) · Cell · doi:10.1016/j.cell.2005.11.010 · Cited by 44 · see citing works
Garcı́a-Sevilla, J. A., Ventayol, P., Pérez, V., et al. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300356 · Cited by 44 · see citing works
Kientsch, U., Bürgi, S., Ruedeberg, C., et al. (2001) · Pharmacopsychiatry · doi:10.1055/s-2001-15452 · Cited by 38 · see citing works
Ruban, A., Avissar, S., & Schreiber, G. (2005) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.08.007 · Cited by 38 · see citing works
Self-citationChronic Treatment of C6 Glioma Cells with Antidepressant Drugs Results in a Redistribution of Gsα
Donati, R. J., Thukral, C., & Rasenick, M. M. (2001) · Molecular Pharmacology · doi:10.1124/mol.59.6.1426 · Cited by 37 · see citing works
Li, X., Huston, E., Lynch, M. J., et al. (2006) · Biochemical Journal · doi:10.1042/bj20051560 · Cited by 36 · see citing works
Interaction of Antibipolar and Antidepressant Treatments with Receptor-Coupled G Proteins
Avissar, S., & Schreiber, G. (1992) · Pharmacopsychiatry · doi:10.1055/s-2007-1014387 · Cited by 36 · see citing works
Self-citationSulser, F. (1984) · PubMed · Cited by 36 · see citing works
Kyosseva, S. V. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00180-9 · Cited by 35 · see citing works
Stimulation of immediate early gene expression by desipramine in rat brain
Dahmen, N., Fehr, C., Reuss, S., & Hiemke, C. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(96)00361-7 · Cited by 31 · see citing works
Chronic Treatment with Mood Stabilizers Increases Membrane GRK3 in Rat Frontal Cortex
Ertley, R. N., Bazinet, R. P., Lee, H., Rapoport, S. I., & Rao, J. S. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.022 · Cited by 25 · see citing works
Miyata, S., Hamamura, T., Lee, Y., Miki, M., Habara, T., Oka, T., Endo, S., Taoka, H., & Kuroda, S. (2004) · Psychopharmacology · doi:10.1007/s00213-004-2072-7 · Cited by 25 · see citing works
Miralles, A. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00306-4 · Cited by 23 · see citing works
Hypericin?an inhibitor of proteasome function
Pajonk, F., Scholber, J., & Fiebich, B. L. (2005) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-004-0933-8 · Cited by 22 · see citing works
Clinical Research on Antipsychotics in Bipolar Disorder
CHOU, J. C.-Y., Solhkhah, R., & Serper, M. R. (2000) · Journal of Psychiatric Practice · doi:10.1097/00131746-200011000-00003 · Cited by 22 · see citing works
Arresting autoimmunity by blocking β-arrestin 1
Frederick, T. J., & Miller, S. D. (2007) · Nature Immunology · doi:10.1038/ni0807-791 · Cited by 12 · see citing works
Blocking Them All: β-Arrestins Inhibit Cellular Signaling
Lohse, M. J., & Klenk, C. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.08.015 · Cited by 5 · see citing works
Volkow (1999) · doi:10.1002/(sici)1098-2396(199901)31:1
Flagged first, then by citations
Cited by
Sorted by citations
Antidepressants increase human hippocampal neurogenesis by activating the glucocorticoid receptor
Anacker, C., Zunszain, P. A., Cattaneo, A., Carvalho, L. A., Garabedian, M. J., Thuret, S., Price, J., & Pariante, C. M. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.26 · Cited by 435 · see citing works
Song, C., Orlandi, C., Sutton, L. P., & Martemyanov, K. A. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.007533 · Cited by 30 · see citing works
Golan, M., Schreiber, G., & Avissar, S. (2010) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.160218 · Cited by 24 · see citing works
Self-citation
- Authors
- Golan, M., Schreiber, G., & Avissar, S.
- Affiliations
- Ben-Gurion University of the Negev (IL)
- ORCID
- Golan, Moran
- Venue
- Current Pharmaceutical Design
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2009-05-01
- Volume
- 15
- Issue
- 14
- Pages
- 1699-1708
- ISSN
- 1381-6128 (ISSN-L)
- OpenAlex
- W2094317231
- Cited by
- 22
- References
- 126
- Citations by year
- 2026: 1 · 2022: 1 · 2019: 2 · 2018: 1 · 2017: 2 · 2016: 2 · 2013: 3 · 2012: 3
- FWCI
- 1.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Pharmaceutical Design (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
- Keywords
- antidepressants, beta-arrestin, G protein-coupled receptors, G protein-coupled receptor kinases, receptor desensitization, receptor down-regulation, scaffold proteins, G protein-independent signaling, MAPK signaling, transcriptional regulation, CREB, P300, monoamine reuptake
- MeSH terms
- beta-Arrestins, Animals, Antidepressive Agents, Depressive Disorder, Humans, Transcription, Genetic, Signal Transduction, Drug Delivery Systems, Arrestins, Receptors, G-Protein-Coupled, G-Protein-Coupled Receptor Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review